4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride

C127H210Cl9F3N24O30S6 — CID 160541616

IUPAC4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride
SMILESCCCCCc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(S(=O)(=O)N(C)C)CC3)CC2)cc1.CCCCOc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(C(=O)N4CCN(C)CC4)CC3)CC2)cc1.CCCCOc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(CCCC(F)(F)F)CC3)CC2)cc1.CCCCOc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(CCN4CCOCC4)CC3)CC2)cc1.CCCCOc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(c4ccc(OC)c(OC)c4)CC3)CC2)cc1.Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl
InChIInChI=1S/C28H40N4O7S.C26H42N6O6S.C26H43N5O6S.C24H37F3N4O5S.C23H39N5O6S2.9ClH/c1-4-5-20-39-24-9-6-22(7-10-24)31-16-18-32(19-17-31)40(35,36)28(27(33)29-34)12-14-30(15-13-28)23-8-11-25(37-2)26(21-23)38-3;1-3-4-21-38-23-7-5-22(6-8-23)29-17-19-32(20-18-29)39(36,37)26(24(33)27-35)9-11-30(12-10-26)25(34)31-15-13-28(2)14-16-31;1-2-3-20-37-24-6-4-23(5-7-24)30-14-16-31(17-15-30)38(34,35)26(25(32)27-33)8-10-28(11-9-26)12-13-29-18-21-36-22-19-29;1-2-3-19-36-21-7-5-20(6-8-21)30-15-17-31(18-16-30)37(34,35)23(22(32)28-33)10-13-29(14-11-23)12-4-9-24(25,26)27;1-4-5-6-7-20-8-10-21(11-9-20)26-16-18-27(19-17-26)35(31,32)23(22(29)24-30)12-14-28(15-13-23)36(33,34)25(2)3;;;;;;;;;/h6-11,21,34H,4-5,12-20H2,1-3H3,(H,29,33);5-8,35H,3-4,9-21H2,1-2H3,(H,27,33);4-7,33H,2-3,8-22H2,1H3,(H,27,32);5-8,33H,2-4,9-19H2,1H3,(H,28,32);8-11,30H,4-7,12-19H2,1-3H3,(H,24,29);9*1H
InChIKeyGZEUGCVPYSISEL-UHFFFAOYSA-N
MW3121.69 g/mol
LogP12.71
Rot. Bonds51

About 4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride

4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride (PubChem CID 160541616) has the molecular formula C127H210Cl9F3N24O30S6 and a molecular weight of 3121.69 g/mol. Its IUPAC name is 4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride.

Molecular Properties

Compound Name4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride
PubChem CID160541616
Molecular FormulaC127H210Cl9F3N24O30S6
Molecular Weight3121.69 g/mol
Exact Mass3115.11
IUPAC Name4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride
SMILESCCCCCc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(S(=O)(=O)N(C)C)CC3)CC2)cc1.CCCCOc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(C(=O)N4CCN(C)CC4)CC3)CC2)cc1.CCCCOc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(CCCC(F)(F)F)CC3)CC2)cc1.CCCCOc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(CCN4CCOCC4)CC3)CC2)cc1.CCCCOc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(c4ccc(OC)c(OC)c4)CC3)CC2)cc1.Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl
InChIInChI=1S/C28H40N4O7S.C26H42N6O6S.C26H43N5O6S.C24H37F3N4O5S.C23H39N5O6S2.9ClH/c1-4-5-20-39-24-9-6-22(7-10-24)31-16-18-32(19-17-31)40(35,36)28(27(33)29-34)12-14-30(15-13-28)23-8-11-25(37-2)26(21-23)38-3;1-3-4-21-38-23-7-5-22(6-8-23)29-17-19-32(20-18-29)39(36,37)26(24(33)27-35)9-11-30(12-10-26)25(34)31-15-13-28(2)14-16-31;1-2-3-20-37-24-6-4-23(5-7-24)30-14-16-31(17-15-30)38(34,35)26(25(32)27-33)8-10-28(11-9-26)12-13-29-18-21-36-22-19-29;1-2-3-19-36-21-7-5-20(6-8-21)30-15-17-31(18-16-30)37(34,35)23(22(32)28-33)10-13-29(14-11-23)12-4-9-24(25,26)27;1-4-5-6-7-20-8-10-21(11-9-20)26-16-18-27(19-17-26)35(31,32)23(22(29)24-30)12-14-28(15-13-23)36(33,34)25(2)3;;;;;;;;;/h6-11,21,34H,4-5,12-20H2,1-3H3,(H,29,33);5-8,35H,3-4,9-21H2,1-2H3,(H,27,33);4-7,33H,2-3,8-22H2,1H3,(H,27,32);5-8,33H,2-4,9-19H2,1H3,(H,28,32);8-11,30H,4-7,12-19H2,1-3H3,(H,24,29);9*1H
InChIKeyGZEUGCVPYSISEL-UHFFFAOYSA-N
XLogP12.71
TPSA594.73 Ų
H-Bond Donors10
H-Bond Acceptors40
Rotatable Bonds51
Heavy Atoms199
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003121.69
LogP ≤ 512.71
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1040

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'}, {'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride?
The IUPAC name of 4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride (CID 160541616) is 4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride.
What is the SMILES notation for 4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride?
The canonical SMILES for 4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride is CCCCCc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(S(=O)(=O)N(C)C)CC3)CC2)cc1.CCCCOc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(C(=O)N4CCN(C)CC4)CC3)CC2)cc1.CCCCOc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(CCCC(F)(F)F)CC3)CC2)cc1.CCCCOc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(CCN4CCOCC4)CC3)CC2)cc1.CCCCOc1ccc(N2CCN(S(=O)(=O)C3(C(=O)NO)CCN(c4ccc(OC)c(OC)c4)CC3)CC2)cc1.Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.
What is the InChIKey of 4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride?
The InChIKey is GZEUGCVPYSISEL-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H40N4O7S.C26H42N6O6S.C26H43N5O6S.C24H37F3N4O5S.C23H39N5O6S2.9ClH/c1-4-5-20-39-24-9-6-22(7-10-24)31-16-18-32(19-17-31)40(35,36)28(27(33)29-34)12-14-30(15-13-28)23-8-11-25(37-2)26(21-23)38-3;1-3-4-21-38-23-7-5-22(6-8-23)29-17-19-32(20-18-29)39(36,37)26(24(33)27-35)9-11-30(12-10-26)25(34)31-15-13-28(2)14-16-31;1-2-3-20-37-24-6-4-23(5-7-24)30-14-16-31(17-15-30)38(34,35)26(25(32)27-33)8-10-28(11-9-26)12-13-29-18-21-36-22-19-29;1-2-3-19-36-21-7-5-20(6-8-21)30-15-17-31(18-16-30)37(34,35)23(22(32)28-33)10-13-29(14-11-23)12-4-9-24(25,26)27;1-4-5-6-7-20-8-10-21(11-9-20)26-16-18-27(19-17-26)35(31,32)23(22(29)24-30)12-14-28(15-13-23)36(33,34)25(2)3;;;;;;;;;/h6-11,21,34H,4-5,12-20H2,1-3H3,(H,29,33);5-8,35H,3-4,9-21H2,1-2H3,(H,27,33);4-7,33H,2-3,8-22H2,1H3,(H,27,32);5-8,33H,2-4,9-19H2,1H3,(H,28,32);8-11,30H,4-7,12-19H2,1-3H3,(H,24,29);9*1H.
What are the key properties of 4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride?
4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride has a molecular weight of 3121.69 g/mol, XLogP of 12.71, 51 rotatable bonds, 10 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-1-(3,4-dimethoxyphenyl)-N-hydroxypiperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4-methylpiperazine-1-carbonyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(2-morpholin-4-ylethyl)piperidine-4-carboxamide;4-[4-(4-butoxyphenyl)piperazin-1-yl]sulfonyl-N-hydroxy-1-(4,4,4-trifluorobutyl)piperidine-4-carboxamide;1-(dimethylsulfamoyl)-N-hydroxy-4-[4-(4-pentylphenyl)piperazin-1-yl]sulfonylpiperidine-4-carboxamide;nonahydrochloride is sourced from PubChem (CID 160541616), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).